10846 studies found for:    "Cardiovascular Agents"
Show Display Options
Rank Status Study
1 Completed The Evening Versus Morning Polypill Utilization Study
Conditions: Cardiovascular Disease;   Cerebrovascular Disease;   Peripheral Arterial Disease
Intervention: Drug: Cardiovascular Agents
2 Completed UMPIRE - Use of a Multidrug Pill In Reducing Cardiovascular Events
Condition: Cardiovascular Diseases
Interventions: Drug: polypill;   Drug: Usual cardiovascular medications
3 Completed Cardiovascular Medication Use Before First Myocardial Infarction
Condition: Myocardial Infarction
Intervention:
4 Terminated Synchronization to Improve Non-Adherence to Cardiovascular Medications
Conditions: Chronic Disease;   Cardiovascular Disease;   Diabetes Mellitus
Intervention: Behavioral: Prescription synchronization
5 Completed REal World Information on Cardiovascular Drug Management Patterns in Acute Coronary Syndrome paTients
Condition: Acute Coronary Syndrome
Intervention:
6 Unknown  The Effect of Providing Free Samples of Generic Cardiovascular Medications to Physicians
Conditions: Hypertension;   Hyperlipidemia
Intervention: Behavioral: Free Generic Samples (hydrochlorothiazide, simvastatin)
7 Completed Study to Improve Quality of Care and Patient Health in the Field of Cardiovascular Risk Factors in General Practice
Condition: High Risk Hypertensive Patients
Interventions: Other: Cardiovascular drugs strategies;   Behavioral: Compliance;   Behavioral: Exercise;   Behavioral: Stop Smoking;   Behavioral: Diet;   Other: Feed Back
8 Suspended Drug Interaction Study of ACT-334441 With Cardiovascular Medications in Healthy Subjects
Condition: Healthy Subjects
Interventions: Drug: ACT-334441 2 mg;   Drug: ACT-334441 4 mg;   Drug: placebo;   Drug: atenolol;   Drug: diltiazem ER
9 Recruiting Rate Control in Atrial Fibrillation II
Conditions: Atrial Fibrillation;   Permanent Atrial Fibrillation
Interventions: Drug: Metoprolol;   Drug: Diltiazem
10 Recruiting Pharmacogenetic Trial of Doxazosin for Treatment of Cocaine Abuse
Condition: Cocaine Dependence
Interventions: Drug: Doxazosin;   Drug: Placebo
11 Suspended Research Into the Effect of a Clot-dissolving Agent and Its Inhibitor
Condition: Acute Ischemic Stroke
Intervention:
12 Completed Custodiol-HTK Solution as a Cardioplegic Agent
Conditions: Coronary Artery Disease;   Myocardial Ischemia;   Coronary Disease;   Heart Diseases;   Valvular Heart Disease
Interventions: Drug: Custodiol HTK;   Drug: Cold Blood Cardioplegia
13 Unknown  Cardiovascular Effects of Salvia Miltiorrhiza Extract (Danshen)
Conditions: Dyslipidemias;   Hypertension;   Vasodilation;   Oxidative Stress;   Inflammation
Interventions: Dietary Supplement: Salvia miltiorrhiza extract;   Dietary Supplement: Placebo
14 Completed
Has Results
Efficacy of Changing to TRAVATAN® From Prior Therapy
Conditions: Open-angle Glaucoma;   Ocular Hypertension
Intervention: Drug: Travoprost 0.004% BAK-free
15 Completed A Trial of Tadalafil and Glycemic Traits
Conditions: Cardiovascular Disease;   Insulin Resistance;   Glucose Intolerance;   Obesity
Interventions: Drug: Tadalafil;   Drug: Placebo
16 Completed
Has Results
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an ACEI or ARB and an Additional Antihypertensive Medication
Condition: Type 2 Diabetes
Interventions: Drug: Dapagliflozin;   Drug: Placebo matching Dapagliflozin
17 Completed
Has Results
The Effect of Nebivolol on Endothelial Dysfunction in African Americans With Hypertension
Condition: High Blood Pressure
Interventions: Drug: Nebivolol;   Drug: Metoprolol XL
18 Not yet recruiting Decision Support for Intraoperative Low Blood Pressure
Condition: Hypotension
Interventions: Procedure: Attending real-time decision support;   Procedure: In-room real-time decision support;   Procedure: Attending feedback emails;   Procedure: In-room provider feedback emails;   Device: Anesthesia Information Management System (AIMS);   Device: Perioperative Data Warehouse (PDW);   Procedure: General anesthesia;   Device: Pager system;   Procedure: Central neuraxial anesthesia;   Procedure: Non-cardiac surgery;   Drug: Propofol;   Drug: Sevoflurane;   Drug: Desflurane;   Drug: Isoflurane;   Drug: Ephedrine;   Drug: Phenylephrine;   Drug: Norepinephrine;   Drug: Epinephrine;   Drug: Dobutamine;   Drug: Dopamine;   Drug: Isoproterenol;   Drug: Milrinone;   Drug: Atropine;   Drug: Glycopyrrolate;   Drug: Vasopressin;   Drug: Terlipressin;   Drug: Sodium Chloride 0.9%;   Drug: Ringer's lactate;   Drug: Hydroxyethyl starch solutions;   Drug: Fresh Frozen Plasma;   Drug: Packed Red Blood Cells;   Drug: Albumin solutions;   Drug: Plasma-Lyte;   Drug: Lidocaine;   Drug: Bupivacaine;   Drug: Levobupivacaine;   Drug: Ropivacaine;   Drug: Mepivacaine;   Drug: Tetracaine;   Drug: Prilocaine;   Drug: Procaine;   Drug: Chloroprocaine;   Drug: Benzocaine;   Drug: Articaine
19 Active, not recruiting Dose Adaptation to Offset the Interaction Between Ticagrelor and Ritonavir by Population-based PK Modeling
Condition: Healthy
Interventions: Drug: ticagrelor 180 mg administrated alone;   Drug: Ticagrelor adjusted dose + ritonavir 100mg
20 Recruiting STOP-AUST: The Spot Sign and Tranexamic Acid On Preventing ICH Growth - AUStralasia Trial
Conditions: Intracerebral Haemorrhage;   Stroke
Interventions: Drug: Tranexamic Acid;   Drug: Placebo

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years